Comparative Infectious Risk of Immunosuppressive Therapies Used in Psoriasis


CME - A Review of Localized Office and Home Devices in the Treatment of Psoriasis

Off-Label Uses of Biologic Agents Approved For Psoriasis and Psoriatic Arthritis for Dermatological Conditions: Part I

Inverse Psoriasis: A Review of Topical Therapies


Explaining the Shift to Value-Based Reimbursement in the Setting of Dermatology and Psoriasis

Case Reports

CME - Successful Treatment of Recalcitrant Palmoplantar Pustulosis with Ixekizumab


Alice B. Gottlieb, M.D., Ph.D.

Department of Dermatology, New York Medical College, 

Valhalla, NY

John Y. M. Koo, M.D.

Professor and Vice Chairman of Dermatology University of California-San Francisco Medical Center, San Francisco, Calif. 

Mark Lebwohl, M.D.

Sol and Clara Kest Professor Chairman, Department of Dermatology Icahn School of Medicine at Mount Sinai, New York, N.Y. 

Senior Editors

David R. Bickers, M.D.

Carl Truman Nelson Professor/Chair Dermatology Department, College of Physicians & Surgeons Columbia University Medical Center New York, N.Y.

Andrew Blauvelt, M.D., M.B.A.

President and Investigator, Oregon Medical Research Center, Portland, Ore.

Erin Boh, M.D., Ph.D.

Professor and Chair, Department of Dermatology, Tulane University, School of Medicine, New Orleans, La.

Anne M. Bowcock, Ph.D.

Professor of Genetics, Pediatrics and Medicine Washington University School of Medicine, St. Louis, Mo. 


Jeffrey P. Callen, M.D.

Professor of Medicine (Dermatology) Chief, Division of Dermatology University of Louisville, Louisville, Ky.

Charles N. Ellis, M.D.

William B. Taylor Professor and Associate Chair, Department of Dermatology University of Michigan Medical School, Ann Arbor, Mich.

Amy Paller, M.D.

Professor and Chair Department of Dermatology Professor of Pediatrics Northwestern University’s Feinberg School of Medicine Chicago, Ill.

Dafna D. Gladman, M.D.

Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, Deputy Director, Centre for Prognosis Studies in The Rheumatic Diseases University Health Network Toronto Western Hospital, Toronto, Ontario

Joseph L. Jorizzo, M.D.

Professor, Former and Founding Chair
Dept of Dermatology Wake Forest University School of Medicine, Winston-Salem, N.C.

Gerald G. Krueger, M.D.

Professor, Benning Presidential Endowed Chair Emeritus, Department of Dermatology, University of Utah School of Medicine, Salt Lake City, Utah

John E. Wolf Jr., M.A., M.D.

Professor and Chair Department of Dermatology Baylor College of Medicine Houston, Texas

Associate Editors

Lakshi Aldredge, M.S.N., A.N.P.-C

Jerry Bagel, M.D.

Robin Christensen, B.Sc., M.Sc, Ph.D.

Kelly Cordoro, M.D.

Jeffrey Crowley, M.D.

Kristina Callis Duffin, M.D.

Lawrence Eichenfield, M.D.

Steven Feldman, M.D., Ph.D.

April Armstrong, M.D., M.P.H.

Joel Gelfand, M.D., M.S.C.E.

Chris Griffiths, M.B., M.D.

Percio Gulko, M.D.

Philip Helliwell, M.D.

Richard Langley, M.D.

Linda Stein Gold, M.D

Kenneth Gordon, M.D.

Johann E. Gudjonsson, M.D., Ph.D.

Sylvia Hsu, M.D.

Abby Jacobson, M.S., P.A.-C

Robert Kalb, M.D.

Philip Mease, M.D.

Joe Merola, M.D., M.M.S.C.

Jörg Prinz, M.D.

Lluís Puig, M.D., Ph.D.

Kristian Reich, M.D., Ph.D.

David Rosmarin, M.D.

Arthur Kavanaugh, M.D.

Neil Korman, M.D., Ph.D.

Thomas McCormick, Ph.D.

Abrar Qureshi, M.D., M.P.H.

Ronald Prussick, M.D.

Stephen Stone, M.D.

Eric Ruderman, M.D.

Mona Ståhle, M.D., Ph.D.

Paul Tebbey, Ph.D., M.B.A.

Abby Van Voorhees, M.D.

Jashin J. Wu, M.D.

Melodie Young, M.S.N., A.N.P.-C


National Psoriasis Foundation
6600 SW 92nd Ave. Suite 300
Portland, OR 97223-7195
503-244-7404, 800-723-9166
Fax: 503-245-0626


Melissa Leavitt, Ph.D.
Associate Director of Scientific Communication
Samantha Klingman
Research Programs Coordinator
Michael Siegel, Ph.D.
Vice President of Research Programs


Colby Evans, M.D.
Chair, Board of Directors
Randy Beranek
President and CEO



R.J. Lewis
Founder & CEO
eHealthcare Solutions


810 Bear Tavern Road, Suite 102
Ewing, NJ 08628
Tel: 609.882.8887 x 101

National Psoriasis Foundation Mission
To drive efforts to cure psoriatic disease and improve the lives of those affected.

The National Psoriasis Foundation does not endorse or recommend any treatment regimens, diets, medications, or products. The National Psoriasis Foundation is solely responsible for all content.

THE NATIONAL PSORIASIS FOUNDATION® JOURNAL OF PSORIASIS AND PSORIATIC ARTHRITIS is published by the National Psoriasis Foundation, a 501(c)(3) lay, nonprofit organization dedicated to public education and psoriasis and psoriatic arthritis research. The Psoriasis Foundation is managed by a voluntary Board of Directors and advised on medical issues by a voluntary Medical Board. Tax-deductible donations support the Psoriasis Foundation’s public education and psoriasis research programs. The Foundation’s Annual Report is available by request.

All rights reserved ©National Psoriasis Foundation, 2017. The contents of JOURNAL OF PSORIASIS AND PSORIATIC
ARTHRITIS cannot be reproduced or copied without written permission of the National Psoriasis Foundation, United
States of America.